Immunic, Inc.
IMUX
$0.7272
$0.01421.99%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.56% | -7.37% | 24.60% | 24.94% | 21.58% |
| Total Depreciation and Amortization | 43.81% | 20.72% | 14.02% | 26.67% | 19.32% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -49.19% | 99.62% | -64.97% | -67.33% | -67.60% |
| Change in Net Operating Assets | -20.14% | -97.43% | -57.21% | -42.53% | -48.56% |
| Cash from Operations | -9.68% | -19.68% | -5.46% | -6.09% | -17.68% |
| Capital Expenditure | -7.28% | 20.96% | -153.57% | -113.20% | -27.94% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | -100.00% | 203.99% |
| Cash from Investing | -106.84% | -102.79% | -42,500.00% | -1,300.00% | 193.22% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -92.92% | -73.48% | -98.66% | -98.21% | -98.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.90% | 7,115.97% | 32.93% | 34.10% | 14.02% |
| Foreign Exchange rate Adjustments | -179.18% | -297.33% | -75.79% | -115.00% | 139.22% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,923.95% | 81.68% | 95.28% | 122.29% | 254.32% |